Literature DB >> 24750417

The licence for a custom-made medicinal product is an adaptive licence.

John D Johnston1.   

Abstract

Mesh：

Year:  2014        PMID： 24750417      PMCID： PMC4093936          DOI： 10.1111/bcp.12249

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

Review 1.  Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products.

Authors:  John D Johnston; Peter Feldschreiber
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

Review 2.  Adaptive licensing: taking the next step in the evolution of drug approval.

Authors:  H-G Eichler; K Oye; L G Baird; E Abadie; J Brown; C L Drum; J Ferguson; S Garner; P Honig; M Hukkelhoven; J C W Lim; R Lim; M M Lumpkin; G Neil; B O'Rourke; E Pezalla; D Shoda; V Seyfert-Margolis; E V Sigal; J Sobotka; D Tan; T F Unger; G Hirsch
Journal:  Clin Pharmacol Ther       Date:  2012-02-15       Impact factor: 6.875
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.